111 related articles for article (PubMed ID: 26899660)
1. Chronic TCDD exposure results in the dysregulation of gene expression in splenic B-lymphocytes and in the impairments in T-cell and B-cell differentiation in mouse model.
Feng Y; Tian J; Krylova I; Xu T; Xie HQ; Guo TL; Zhao B
J Environ Sci (China); 2016 Jan; 39():218-227. PubMed ID: 26899660
[TBL] [Abstract][Full Text] [Related]
2. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.
Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N
Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549
[TBL] [Abstract][Full Text] [Related]
3. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.
Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE
J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of TCDD-induced suppression of antibody production: effect on T cell-derived cytokine production in the primary immune reaction of mice.
Ito T; Inouye K; Fujimaki H; Tohyama C; Nohara K
Toxicol Sci; 2002 Nov; 70(1):46-54. PubMed ID: 12388834
[TBL] [Abstract][Full Text] [Related]
5. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.
Phadnis-Moghe AS; Crawford RB; Kaminski NE
Toxicol Sci; 2015 Mar; 144(1):39-50. PubMed ID: 25543051
[TBL] [Abstract][Full Text] [Related]
6. 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.
North CM; Crawford RB; Lu H; Kaminski NE
Toxicol Sci; 2010 Jul; 116(1):99-112. PubMed ID: 20348231
[TBL] [Abstract][Full Text] [Related]
7. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
Sulentic CE; Holsapple MP; Kaminski NE
J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
[TBL] [Abstract][Full Text] [Related]
8. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion.
Karras JG; Morris DL; Matulka RA; Kramer CM; Holsapple MP
Toxicol Appl Pharmacol; 1996 Apr; 137(2):275-84. PubMed ID: 8661353
[TBL] [Abstract][Full Text] [Related]
9. Prenatal TCDD causes persistent modulation of the postnatal immune response, and exacerbates inflammatory disease, in 36-week-old lupus-like autoimmune SNF1 mice.
Mustafa A; Holladay S; Witonsky S; Zimmerman K; Manari A; Countermarsh S; Karpuzoglu E; Gogal R
Birth Defects Res B Dev Reprod Toxicol; 2011 Feb; 92(1):82-94. PubMed ID: 21312323
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
[TBL] [Abstract][Full Text] [Related]
11. Characterization of protein phosphorylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in murine lymphocytes: indirect evidence for a role in the suppression of humoral immunity.
Snyder NK; Kramer CM; Dooley RK; Holsapple MP
Drug Chem Toxicol; 1993; 16(2):135-63. PubMed ID: 8486096
[TBL] [Abstract][Full Text] [Related]
12. Search for the target genes involved in the suppression of antibody production by TCDD in C57BL/6 mice.
Nagai H; Takei T; Tohyama C; Kubo M; Abe R; Nohara K
Int Immunopharmacol; 2005 Feb; 5(2):331-43. PubMed ID: 15652763
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Karras JG; Holsapple MP
Toxicol Appl Pharmacol; 1994 Apr; 125(2):264-70. PubMed ID: 8171434
[TBL] [Abstract][Full Text] [Related]
14. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces suppressor of cytokine signaling 2 in murine B cells.
Boverhof DR; Tam E; Harney AS; Crawford RB; Kaminski NE; Zacharewski TR
Mol Pharmacol; 2004 Dec; 66(6):1662-70. PubMed ID: 15371557
[TBL] [Abstract][Full Text] [Related]
15. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
16. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
Sulentic CE; Holsapple MP; Kaminski NE
Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
[TBL] [Abstract][Full Text] [Related]
17. Functional activation of arylhydrocarbon receptor (AhR) in primary T cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Doi H; Baba T; Tohyama C; Nohara K
Chemosphere; 2003 Jul; 52(4):655-62. PubMed ID: 12738279
[TBL] [Abstract][Full Text] [Related]
18. Activation of the aryl hydrocarbon receptor reduces the number of precursor and effector T cells, but preserves thymic CD4+CD25+Foxp3+ regulatory T cells.
Schulz VJ; Smit JJ; Bol-Schoenmakers M; van Duursen MB; van den Berg M; Pieters RH
Toxicol Lett; 2012 Nov; 215(2):100-9. PubMed ID: 23041608
[TBL] [Abstract][Full Text] [Related]
19. Changes in DNA methylation and gene expression during 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced suppression of the lipopolysaccharide-stimulated IgM response in splenocytes.
McClure EA; North CM; Kaminski NE; Goodman JI
Toxicol Sci; 2011 Apr; 120(2):339-48. PubMed ID: 21212295
[TBL] [Abstract][Full Text] [Related]
20. The long winding road toward understanding the molecular mechanisms for B-cell suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Sulentic CE; Kaminski NE
Toxicol Sci; 2011 Mar; 120 Suppl 1(Suppl 1):S171-91. PubMed ID: 20952503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
